Circulating cardiovascular biomarkers 1-3 years following hypertensive pregnancy disorders: associations with postpartum cardiovascular structure and function

Klepp, Kristina; Moe, Kjartan; Jacobsen, Daniel P.; Sugulle, Meryam; Angel, Kristin; von Lueder, Thomas G.; Dechend, Ralf; Staff, Anne Cathrine

Circulating cardiovascular biomarkers 1-3 years following hypertensive pregnancy disorders: associations with postpartum cardiovascular structure and function

Tools

Preview	PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader 2MB
	MS Word 109kB

Item Type:	Article
Title:	Circulating cardiovascular biomarkers 1-3 years following hypertensive pregnancy disorders: associations with postpartum cardiovascular structure and function
Creators:	Klepp, Kristina, Moe, Kjartan, Jacobsen, Daniel P., Sugulle, Meryam, Angel, Kristin, von Lueder, Thomas G., Dechend, Ralf ORCID: https://orcid.org/0000-0001-6636-3080 and Staff, Anne Cathrine ORCID: https://orcid.org/0000-0001-9247-5721
Abstract:	Hypertensive disorders of pregnancy (HDP) confer increased cardiovascular disease (CVD) risk postpartum. Screening methods targeting women with increased risk are lacking, limiting personalized follow-up. Circulating biomarkers may assist CVD risk stratification. We aimed to assess whether circulating biomarkers were associated with measures of cardiovascular structure and function following HDP and normotensive pregnancies (controls). We examined 275 women 1-3 years postpartum (176 following HDP and 99 parous controls). Circulating biomarkers (hs-CRP, non-HDL cholesterol, glucose, eGFR, cTnT, NT-proBNP, GDF-15, sHLA-G, SAA1) and cardiovascular function and structure measures were examined [pulse wave velocity (PWV), carotid intima-media thickness (CIMT) and echocardiography]. Group differences were tested by Mann-Whitney U test and chi-square. Associations were assessed by univariate regression analyses. A p-value < 0.05 was considered statistically significant. Women following HDP displayed significantly higher rates of hypertension (5% vs. 0%) and metabolic syndrome (7% vs. 1%) than controls. Circulating biomarker levels were similar between study groups. In univariate regression analyses for the prior HDP group, non-HDL cholesterol was significantly associated with PWV and CIMT. Additionally, glucose and hs-CRP were significantly associated with PWV. These associations were not reproduced for controls, except for non-HDL cholesterol which was significantly associated with CIMT. In conclusion, women following HDP and normotensive pregnancies had similar postpartum levels of circulating biomarkers, but circulating biomarkers were significantly associated with measures of arterial stiffness (PWV and CIMT) in women with prior HDP. Our findings support current guidelines recommending CVD follow-up after HDP. Non-HDL cholesterol, glucose and hs-CRP may possibly help refining personalized cardiovascular follow-up postpartum.
Keywords:	Cardiovascular Disease, Cardiovascular Structure and Function, Echocardiography, Hypertension, Hypertensive Disorder of Pregnancy, Postpartum, Preeclampsia
Source:	Reproductive Sciences
ISSN:	1933-7191
Publisher:	Sage Publications
Date:	21 August 2026
Official Publication:	https://doi.org/10.1007/s43032-026-02171-y
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Downloads

Downloads per month over past year